Selected research
Market Structure
Global Valbenazine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Valbenazine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Valbenazine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Valbenazine include Vcare Pharmatech, Toronto Research Chemicals, TargetMol, Neurocrine Biosciences, Clearsynth, BOC Sciences and Adooq Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Valbenazine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Valbenazine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Valbenazine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Valbenazine market size, projected growth trends, production technologies, key applications, and end-use industries.
Valbenazine Segment by Company
Vcare Pharmatech
Toronto Research Chemicals
TargetMol
Neurocrine Biosciences
Clearsynth
BOC Sciences
Adooq Bioscience
Valbenazine Segment by Type
40mg Capsule
60mg Capsule
80mg Capsule
Valbenazine Segment by Application
Tardive Dyskinesia
Tourette Syndrome
Valbenazine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valbenazine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valbenazine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valbenazine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Valbenazine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valbenazine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Valbenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Valbenazine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Capsule
- 60mg Capsule
- 80mg Capsule
Applications
- Tardive Dyskinesia
- Tourette Syndrome
Companies covered
- Vcare Pharmatech
- Toronto Research Chemicals
- TargetMol
- Neurocrine Biosciences
- Clearsynth
- BOC Sciences
- Adooq Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Valbenazine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Valbenazine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Valbenazine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Valbenazine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Valbenazine Market Dynamics
- 2.1 Valbenazine Industry Trends
- 2.2 Valbenazine Industry Drivers
- 2.3 Valbenazine Industry Opportunities and Challenges
- 2.4 Valbenazine Industry Restraints
3 Valbenazine Market by Manufacturers
- 3.1 Global Valbenazine Revenue by Manufacturers (2021-2026)
- 3.2 Global Valbenazine Sales by Manufacturers (2021-2026)
- 3.3 Global Valbenazine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Valbenazine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Valbenazine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Valbenazine Manufacturers, Product Type & Application
- 3.7 Global Valbenazine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Valbenazine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Valbenazine Players Market Share by Revenue in 2025
- 3.8.3 2025 Valbenazine Tier 1, Tier 2, and Tier 3
4 Valbenazine Market by Type
- 4.1 Valbenazine Type Introduction
- 4.1.1 40mg Capsule
- 4.1.2 60mg Capsule
- 4.1.3 80mg Capsule
- 4.2 Global Valbenazine Sales by Type
- 4.2.1 Global Valbenazine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Valbenazine Sales by Type (2021-2032)
- 4.2.3 Global Valbenazine Sales Market Share by Type (2021-2032)
- 4.3 Global Valbenazine Revenue by Type
- 4.3.1 Global Valbenazine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Valbenazine Revenue by Type (2021-2032)
- 4.3.3 Global Valbenazine Revenue Market Share by Type (2021-2032)
5 Valbenazine Market by Application
- 5.1 Valbenazine Application Introduction
- 5.1.1 Tardive Dyskinesia
- 5.1.2 Tourette Syndrome
- 5.2 Global Valbenazine Sales by Application
- 5.2.1 Global Valbenazine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Valbenazine Sales by Application (2021-2032)
- 5.2.3 Global Valbenazine Sales Market Share by Application (2021-2032)
- 5.3 Global Valbenazine Revenue by Application
- 5.3.1 Global Valbenazine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Valbenazine Revenue by Application (2021-2032)
- 5.3.3 Global Valbenazine Revenue Market Share by Application (2021-2032)
6 Global Valbenazine Sales by Region
- 6.1 Global Valbenazine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Valbenazine Sales by Region (2021-2032)
- 6.2.1 Global Valbenazine Sales by Region (2021-2026)
- 6.2.2 Global Valbenazine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Valbenazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Valbenazine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Valbenazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Valbenazine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Valbenazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Valbenazine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Valbenazine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Valbenazine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Valbenazine Revenue by Region
- 7.1 Global Valbenazine Revenue by Region
- 7.1.1 Global Valbenazine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Valbenazine Revenue by Region (2021-2026)
- 7.1.3 Global Valbenazine Revenue by Region (2027-2032)
- 7.1.4 Global Valbenazine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Valbenazine Revenue (2021-2032)
- 7.2.2 North America Valbenazine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Valbenazine Revenue (2021-2032)
- 7.3.2 Europe Valbenazine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Valbenazine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Valbenazine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Valbenazine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Valbenazine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Vcare Pharmatech
- 8.1.1 Vcare Pharmatech Company Information
- 8.1.2 Vcare Pharmatech Business Overview
- 8.1.3 Vcare Pharmatech Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Vcare Pharmatech Valbenazine Product Portfolio
- 8.1.5 Vcare Pharmatech Recent Developments
- 8.2 Toronto Research Chemicals
- 8.2.1 Toronto Research Chemicals Company Information
- 8.2.2 Toronto Research Chemicals Business Overview
- 8.2.3 Toronto Research Chemicals Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Toronto Research Chemicals Valbenazine Product Portfolio
- 8.2.5 Toronto Research Chemicals Recent Developments
- 8.3 TargetMol
- 8.3.1 TargetMol Company Information
- 8.3.2 TargetMol Business Overview
- 8.3.3 TargetMol Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 TargetMol Valbenazine Product Portfolio
- 8.3.5 TargetMol Recent Developments
- 8.4 Neurocrine Biosciences
- 8.4.1 Neurocrine Biosciences Company Information
- 8.4.2 Neurocrine Biosciences Business Overview
- 8.4.3 Neurocrine Biosciences Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Neurocrine Biosciences Valbenazine Product Portfolio
- 8.4.5 Neurocrine Biosciences Recent Developments
- 8.5 Clearsynth
- 8.5.1 Clearsynth Company Information
- 8.5.2 Clearsynth Business Overview
- 8.5.3 Clearsynth Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Clearsynth Valbenazine Product Portfolio
- 8.5.5 Clearsynth Recent Developments
- 8.6 BOC Sciences
- 8.6.1 BOC Sciences Company Information
- 8.6.2 BOC Sciences Business Overview
- 8.6.3 BOC Sciences Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 BOC Sciences Valbenazine Product Portfolio
- 8.6.5 BOC Sciences Recent Developments
- 8.7 Adooq Bioscience
- 8.7.1 Adooq Bioscience Company Information
- 8.7.2 Adooq Bioscience Business Overview
- 8.7.3 Adooq Bioscience Valbenazine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Adooq Bioscience Valbenazine Product Portfolio
- 8.7.5 Adooq Bioscience Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Valbenazine Value Chain Analysis
- 9.1.1 Valbenazine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Valbenazine Production Mode & Process
- 9.2 Valbenazine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Valbenazine Distributors
- 9.2.3 Valbenazine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst